Brian Paliotti
Analyst · KeyBanc Capital Markets. Please state your question
Thank you, Sharon. And thanks everyone for joining us this afternoon. With me today is Teddy Gottwald, our Chairman and CEO. As a reminder, some of the statements made during this conference call may be forward-looking. Relevant factors that could cause actual results to differ materially from those forward-looking statements are contained in our earnings release and in our SEC filings including our most recent Form 10-K. During this call, we may also discuss non-GAAP financial measures included in our earnings release. The earnings release, which can be found on our website, includes a reconciliation of these non-GAAP financial measures to comparable GAAP financial measures. We plan to file our 10-Q later this week and it contains significantly more details on the operations and the performance of the company. Please take time to review it. Our comments today will be referring to the data that was included in last night’s press release. Net income was $62 million, or $5.08 per share, compared to the net income of $57 million, or $4.53 per share for the third quarter of last year. Earnings for both third quarter periods included the impact of valuing an interest rate swap at fair value. Excluding that special item for both periods, earnings for this year’s third quarter would have been $64 million, or $5.25 a share compared to $57 million or $4.52 per share. Petroleum additives operating profit for the quarter was $101 million, which is about $7 million or 6.6% higher than last year’s third quarter performance. Total sales for the quarter decreased by 8.3% to $541 million compared to sales for the same period last year of $590 million. The decrease in petroleum additives revenue in the quarter comparison was mainly driven by FX and price customer mix. The FX or foreign exchange impacts are mainly driven by the Euro and Yen rate versus the U.S. dollar and they accounted for $24 million of the revenue reduction with the price customer mix accounting for $25 million of the quarterly change as some prices have reset. The shipments in lubricant additives has declined but were offset by increases in fuel additives globally. In the quarter and through the first nine months of the year, our shipments were essentially unchanged versus 2014. Lubricant additives volumes have slower than expected but we believe the petroleum additives industry long-term growth rate of 1% to 2% hasn’t changed and we don’t see any new trend in the volume data year-to-date. In the third quarter, similar to the first half, we continue to see a benefit from lower raw material cost offset by the foreign exchange. We continue to invest in research and development in Q3 in support of our customer solutions and have increased those investments by $3 million or 9% in the quarter and by $15 million or 15% for the first three quarters. Throughout 2015, we had experienced movement in crude oil, slower economic growth particularly in Asia and exchange rates. Managing through such changes are normal part of our business. We expect our margins to be in the mid to upper teens over the longer term as they have been in recent years as the fundamentals of the industry has not changed. For the four quarters ended September our average petroleum additives operating margins were 17.5% which is in line with our expectations of the performance over the long-term. On the cash flow for the quarter, items of note including funding our normal dividends of $70 million and using more cash to fund the normal variations in working capital. We've bought back 435,400 shares of stock for a total of $171 million in the quarter. We have also announced an increase in our dividend to $1.60 a share, a 14% increase, and have approved a new share buyback authorization of $500 million which is good through the end of 2018. We continue to operate with very low leverage with debt-to-EBITDA remaining below 1.3 times. In Q3, we continue to execute on our capital investments on unidentified projects which equated to $34 million bringing the year-to-date spend to $84 million. This is our plan for capital expenditures in $100 million to $140 million range, which conclude investing in our new manufacturing facility in Singapore as well as several improvements to our manufacturing and armed research and development infrastructure around the world. In August, we announced the second phase of construction in Singapore which includes additional component production units that will more than double our investment in that facility. The Phase 2 construction is scheduled to be completed in 2017. We still anticipate capital expenditures to remain higher than normal range for the next several years in the $150 million plus range in support of our global growth plan which has revised up versus what we had discussed for the last few quarters, primarily due to our phase 2 Singapore announcement. In summary, our business is performing well. It is in line with our long-term view. We continue to invest heavily in research and development and additional capacity to support our customers worldwide and to meet our long-term growth goals. We believe the fundamentals of how we run our business continues to pay dividends for all of our stakeholders. Sharon, that completes our planned comments. We would like to open it up the line for any questions, please.